GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The ...
GSK recorded positive topline data in a late stage trial of its respiratory syncytial virus vaccine combined with a shingles vaccine in treating adults 50 years and older.
GSK plc (LSE/NYSE: GSK) today announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, reactogenicity and safety of AREXVY (Respiratory ...
British drugmaker GSK said on Wednesday its respiratory syncytial virus (RSV) vaccine, when given together with its shingles ...
After 25 years as a pediatric infectious diseases specialist, Asunción Mejías is too familiar with the deadly ...
The N.C. Department of Health and Human Services is encouraging everyone 6 months and older to get their seasonal flu shot and COVID-19 vaccine. Both vaccines have been updated for ...
The following is a summary of “Impact of antibiotic therapy in patients with respiratory viral infections: a retrospective ...
San Diego County is become the fifth location in California to report the environmental detection of H5 influenza virus, ...
RALEIGH — The N.C. Department of Health and Human Services (NCDHHS ... against long term health implications of getting ...
In this case, their findings serve as a bellwether for potential public health concerns, allowing the county's surveillance ...
Senior living providers in Florida are advising their residents, particularly those with underlying health conditions, to ...
Will flu season 2024-2025 be a bad one? Here's what infectious disease doctors want us all to know this year. The post When ...